Related Experiment Video
Updated: Jun 11, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
High-Dimensional Mediation Analysis with Network Mediators: Applications to Pediatric Acute Lymphoblastic Leukemia
Pediatric cancer survivors with acute lymphoblastic leukemia (ALL) may face neurocognitive issues. This study reveals how brain connectivity mediates these effects, offering hope for targeted interventions.
Area of Science:
- Neuroscience
- Oncology
- Biostatistics
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Survivors often experience long-term neurocognitive deficits.
- Understanding the mechanisms behind these deficits is crucial for developing interventions.
Purpose of the Study:
- To investigate the mechanisms of treatment-related neurocognitive side effects in pediatric ALL survivors.
- To utilize brain connectivity network data from the TOTXVI clinical trial.
- To propose and validate a novel statistical method for analyzing high-dimensional mediation effects in brain networks.
Main Methods:
- Development of a novel network mediation structural shrinkage (NMSS) prior for high-dimensional mediation analysis.
- Incorporation of brain structural connectivity network data as mediators.
- Application of the NMSS method to TOTXVI clinical trial data and simulation studies.
Main Results:
- The NMSS method accurately estimates high-dimensional coefficients and mediation effects, accounting for network properties.
- Simulation studies demonstrated the method's effectiveness and superiority over existing approaches.
- Analysis of TOTXVI data revealed significant mediation effects of brain connectivity on visual processing speed, influenced by IT intensity.
Conclusions:
- Brain connectivity plays a significant role in mediating neurocognitive deficits in pediatric ALL survivors.
- The proposed NMSS method provides a powerful tool for analyzing complex brain network data.
- Findings suggest potential for targeted interventions to mitigate neurocognitive impairments in survivors.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017